Cigna Story

CI -- USA Stock

USD 219.51 4.56 2.12%

Macroaxis Story

Cigna is scheduled to announce its earnings today. The next earnings report is expected on the 29th of April 2021. As many millenniums are getting excited about healthcare space, it is only fair to concentrate on the feasibility of shorting Cigna. I will address why stockholders ignored this entity since the beginning of the current economic outlook.

Published over three weeks ago

View all stories for Cigna Corp | View All Stories

Will analysts have more confidence in Cigna (NYSE:CI) March?

The entity reports 36.61 B of total liabilities with total debt to equity ratio (D/E) of 0.76, which is normal for its line of buisiness.

What is the right price you would pay to acquire a share of Cigna Corp? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated.

Please read more on our stock advisor page.

What is happening with Cigna Corp this year

Annual and quarterly reports issued by Cigna Corp are formal financial statements that are published yearly and quarterly and sent to Cigna stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.

Companies such as Cigna Corp often view their annual report as an effective marketing tool to disseminate their perspective on company future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.

How Cigna utilizes its cash?

To perform a cash flow analysis of Cigna Corp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Cigna Corp is receiving and how much cash it distributes out in a given period. The Cigna Corp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Cigna Corp Net Cash Flow from Operations is most likely to increase significantly in the upcoming years. The last year's value of Net Cash Flow from Operations was reported at 10.35 Billion

Acquisition by Elder Granger of 226 shares of Cigna Corp subject to Rule 16b-3

Legal trades by Cigna Corp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

Cigna insider trading alert for grant of common stock $.01 par value by Elder Granger, the corporate stakeholder, on 2nd of March 2021. This event was filed by Cigna Corp with SEC on 2021-03-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down Cigna Corp Indicators

Earning per share calculations of Cigna is based on official Zacks consensus of 8 analysts regarding Cigna's future annual earnings. Given the historical accuracy of 93.05%, the future earnings per share of the company is estimated to be 18.56 with the lowest and highest values of 18.45 and 18.63, respectively. Please note that this consensus of annual earnings estimates for the firm is an estimate of EPS before non-recurring items and including employee stock options expenses.

Is Cigna a risky opportunity?

Let's check the volatility. Cigna is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Cigna (NYSE:CI) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. locking in a share of a Cigna stock makes you a part-owner of that company.

Cigna Current Consensus

Here is the current trade recommendation based on an ongoing consensus estimate among financial analysis covering Cigna. The Cigna consensus assessment is calculated by taking the average estimates from all of the analysts covering Cigna

Strong Buy

Buy

Hold

Strong Buy	13	81.25
Buy	2	12.5
Hold	1	6.25
Sell	0	0.0
Strong Sell	0	0.0

Another 3 percent drop for Cigna

Current Total Risk Alpha is up to -0.06. Price may drop again. As of the 4th of February, Cigna shows the Mean Deviation of 1.91, downside deviation of 1.83, and Risk Adjusted Performance of 0.145. Cigna technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Cigna, which can be compared to its rivals. Please confirm Cigna coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Cigna is priced correctly, providing market reflects its regular price of 210.86 per share. Given that Cigna has jensen alpha of 0.2311, we suggest you to validate Cigna's prevailing market performance to make sure the company can sustain itself at a future point.

Our Final Take On Cigna

While some other entities in the healthcare plans industry are either recovering or due for a correction, Cigna may not be as strong as the others in terms of longer-term growth potentials. While some stockholders may not share our view, we believe it may be a good time to increase your existing holdings in Cigna. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Cigna.

About Contributor

Ellen Johnson is a Member of Macroaxs Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cigna Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC